Repository to Study Host-Microbiome Interactions
This study is collecting samples of the microbiome (the bacteria and other tiny living things that live inside and on your body) from people to create a repository. Researchers will use these samples to better understand how the microbiome affects health and disease. This is not a study testing a new medicine, but rather collecting information for future research. People of any age can participate, though only those over 3 years old will be seen at the NIH clinic. The main goal is to collect biological samples to learn more about how the microbiome responds in healthy and sick individuals.
- Study design
- This is an observational study aiming to enroll 600 participants. It is designed to collect biological samples for future research.
- What's involved
- You will fill out a questionnaire and provide at least one biological sample. The study will collect samples until the end of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Repository to Study Host-Microbiome Interactions in Health and Disease
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Suchitra K Hourigan, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Allergy and Infectious Diseases (NIAID)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Collection of biological specimens to assess host microbiome responseThrough End of Study
To provide samples for use in secondary research for evaluation of assay validation, optimization of techniques for collection, storage, processing and analyzing samples, control samples for research tests in other studies, and identification of potential targets from which clinical trials can be designed to better understand or mitigate microbiome associated diseases